Cryptococcal Infections: Changing Epidemiology and Implications for Therapy

Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis

(2013) Gregory P. Bisson et al.   CLINICAL INFECTIOUS DISEASES

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis

(2012) Joseph N. Jarvis et al.   AIDS

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine

(2012) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of Four Assays for the Detection of Cryptococcal Antigen

(2012) M. J. Binnicker et al.   Clinical and Vaccine Immunology

Letter re: Marr editorial

(2012) J. R. Harris et al.   CLINICAL INFECTIOUS DISEASES

Transmission of Infection With Human Allografts: Essential Considerations in Donor Screening

(2012) J. A. Fishman et al.   CLINICAL INFECTIOUS DISEASES

Reconsidering Cryptococcal Antigen Screening in the U.S. Among Persons With CD4

(2012) R. Rajasingham et al.   CLINICAL INFECTIOUS DISEASES

Integrating Cryptococcal Antigen Screening and Pre-Emptive Treatment into Routine HIV Care

(2012) Radha Rajasingham et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Correlation of antifungal susceptibility and molecular type within theCryptococcus neoformans/C. gattiispecies complex

(2012) Luciana Trilles et al.   MEDICAL MYCOLOGY

Infections and Organ Transplantation

(2012) Paolo A. Grossi et al.   TRANSPLANTATION

Cryptococcal Meningitis Treatment Strategies in Resource-Limited Settings: A Cost-Effectiveness Analysis

(2012) Radha Rajasingham et al.   PLOS MEDICINE

Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients 2010 Data Report

(2011)   AMERICAN JOURNAL OF TRANSPLANTATION

Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal Meningitis

(2011) A. Loyse et al.   CLINICAL INFECTIOUS DISEASES

Transmission of Cryptococcus neoformans by Organ Transplantation

(2011) J. W. Baddley et al.   CLINICAL INFECTIOUS DISEASES

Cryptococcus gattii: The Tip of the Iceberg

(2011) K. A. Marr   CLINICAL INFECTIOUS DISEASES

Cryptococcus gattii in the United States: Clinical Aspects of Infection With an Emerging Pathogen

(2011) J. R. Harris et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of a Newly Developed Lateral Flow Immunoassay for the Diagnosis of Cryptococcosis

(2011) M. D. Lindsley et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of a Novel Point-of-Care Cryptococcal Antigen Test on Serum, Plasma, and Urine From Patients With HIV-Associated Cryptococcal Meningitis

(2011) J. N. Jarvis et al.   CLINICAL INFECTIOUS DISEASES

Preventing deaths from cryptococcal meningitis: from bench to bedside

(2011) Monika Roy et al.   Expert Review of Anti-Infective Therapy

Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis

(2011) Conrad K. Muzoora et al.   JOURNAL OF INFECTION

Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial

(2011) Rosalind Parkes-Ratanshi et al.   LANCET INFECTIOUS DISEASES

Cryptococcosis in China (1985–2010): Review of Cases from Chinese Database

(2011) Chen Yuchong et al.   MYCOPATHOLOGIA

Human Pathogenic Fungi in China—Emerging Trends from Ongoing National Survey for 1986, 1996, and 2006

(2011) S. X. Wu et al.   MYCOPATHOLOGIA

Pulmonary Cryptococcosis

(2011) Kyle Brizendine et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

How I Treat Cryptococcosis in Organ Transplant Recipients

(2011) Nina Singh   TRANSPLANTATION

Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme

(2010) Joseph N Jarvis et al.   AIDS

In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus gattii Isolates

(2010) F. Hagen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cryptococcal Antigen Screening for Patients Initiating Antiretroviral Therapy: Time for Action

(2010) Joseph N. Jarvis et al.   CLINICAL INFECTIOUS DISEASES

Unrecognized Pretransplant and Donor‐Derived Cryptococcal Disease in Organ Transplant Recipients

(2010) Hsin‐Yun Sun et al.   CLINICAL INFECTIOUS DISEASES

Cost‐Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV‐Infected Persons with a CD4+Cell Count ⩽100 Cells/μL Who Start HIV Therapy in Resource‐Limited Settings

(2010) David B. Meya et al.   CLINICAL INFECTIOUS DISEASES

Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

(2010) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Early versus Delayed Initiation of Antiretroviral Therapy for Concurrent HIV Infection and Cryptococcal Meningitis in Sub‐Saharan Africa

(2010) Azure T. Makadzange et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

In Vitro Susceptibility of the Yeast Pathogen Cryptococcus to Fluconazole and Other Azoles Varies with Molecular Genotype

(2010) H. S. Chong et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Cryptococcosis in Solid Organ Transplant Recipients

(2009) N. Singh et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Donor-Derived Infections in Solid Organ Transplant Recipients

(2009) P. A. Grossi et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Phase II Randomized Trial of Amphotericin B Alone or Combined with Fluconazole in the Treatment of HIV‐Associated Cryptococcal Meningitis

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Independent Association between Rate of Clearance of Infection and Clinical Outcome of HIV‐Associated Cryptococcal Meningitis: Analysis of a Combined Cohort of 262 Patients

(2009) Tihana Bicanic et al.   CLINICAL INFECTIOUS DISEASES

Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa

(2009) Joseph N. Jarvis et al.   CLINICAL INFECTIOUS DISEASES

Combination Flucytosine and High‐Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi

(2009) Jesse C. Nussbaum et al.   CLINICAL INFECTIOUS DISEASES

Correlation of Genotype and In Vitro Susceptibilities of Cryptococcus gattii Strains from the Pacific Northwest of the United States

(2009) N. Iqbal et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular Evidence That the Range of the Vancouver Island Outbreak ofCryptococcus gattiiInfection Has Expanded into the Pacific Northwest in the United States

(2009) Edmond J. Byrnes III et al.   JOURNAL OF INFECTIOUS DISEASES

Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial

(2009) Andrew R. Zolopa et al.   PLoS One

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

(2008) Stephen D Lawn et al.   AIDS

Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans

(2008) G. R. Thompson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis

(2008) Françoise Dromer et al.   PLoS One